TP63 Gene Limb-mammary syndrome Genetic Test
Are you looking for a reliable genetic lab in UAE to perform the TP63 Gene Limb-mammary syndrome Genetic Test? Look no further than DNA Labs UAE. We offer comprehensive genetic testing services, including the TP63 Gene Limb-mammary syndrome Genetic Test, at an affordable cost of AED 4400.0.
Test Components
- Test Name: TP63 Gene Limb-mammary syndrome Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Dysmorphology
- Doctor: Pediatrics
- Test Department: Genetics
Pre Test Information
Prior to undergoing the TP63 Gene Limb-mammary syndrome NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the TP63 Gene Limb-mammary syndrome NGS Genetic DNA Test gene TP63.
Test Details
The TP63 gene plays a crucial role in the development and maintenance of various tissues in the body, including the limbs and mammary glands. Limb-mammary syndrome is a rare genetic disorder caused by mutations in the TP63 gene. This condition is characterized by abnormalities in the limbs, such as missing fingers or toes, and abnormal development of the mammary glands, leading to underdeveloped or absent breasts.
Our TP63 Gene Limb-mammary syndrome Genetic Test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes, including the TP63 gene. By analyzing a blood or saliva sample, this test can identify mutations or changes in the TP63 gene that may be associated with limb-mammary syndrome.
During the test, the DNA in the sample is sequenced, and the data is analyzed to identify any mutations or changes in the TP63 gene. This information can help confirm a diagnosis of limb-mammary syndrome and provide valuable insights into the specific mutation or change in the TP63 gene. It can assist in determining the prognosis, treatment options, and recurrence risk for affected individuals and their families.
If you suspect limb-mammary syndrome or have a family history of the condition, it is crucial to undergo the TP63 Gene Limb-mammary syndrome Genetic Test. Early detection and diagnosis can make a significant difference in managing the condition and providing appropriate care.
At DNA Labs UAE, we are committed to delivering accurate and reliable genetic testing services. Contact us today to schedule your TP63 Gene Limb-mammary syndrome Genetic Test and take a step towards better health.
Test Name | TP63 Gene Limb-mammary syndrome Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TP63 Gene Limb-mammary syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TP63 Gene Limb-mammary syndrome NGS Genetic DNA Test gene TP63 |
Test Details |
The TP63 gene is a gene that provides instructions for making a protein called p63. This protein is involved in the development and maintenance of many different tissues in the body, including the limbs and mammary glands. Limb-mammary syndrome is a rare genetic disorder caused by mutations in the TP63 gene. This condition is characterized by abnormalities in the limbs, such as missing fingers or toes, and abnormal development of the mammary glands, which can lead to underdeveloped or absent breasts. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the TP63 gene. This test can identify mutations or changes in the TP63 gene that may be associated with limb-mammary syndrome. NGS genetic testing is typically performed using a blood or saliva sample. The DNA in the sample is sequenced, and the data is analyzed to identify any mutations or changes in the TP63 gene. This type of genetic testing can help confirm a diagnosis of limb-mammary syndrome and provide information about the specific mutation or change in the TP63 gene. This information can be useful for determining the prognosis, treatment options, and recurrence risk for affected individuals and their families. |